Ledger.Open graph →
SEC Form D · filed September 24, 2018

RespireRx Pharmaceuticals Inc

Offering
$1.5M
Sold
$251K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
GLEN ROCK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Matt Harris · New York, NYDirectorPeter Mullen · New York, NYDirectorSponsor Colony Hills Capital, LLC · Wilbraham, MADirectorLuke J. Atwood · Richmond, VAExec · DirectorChristine K. Funk · Sisters, ORExecAmrit Shahzad · Beverly, MADirectorLeath Bing · New York, NYExec · DirectorClair C. Holley · Calgary, Alberta, CanadaExec · DirectorDonald R. Mclamb, Jr · Wilmington, DEExecGlenn R. Hanson · Wilbraham, MAExec · DirectorCharles Berg · New York, NYExec · DirectorAndrew F. St Pierre · Burlington, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗